Code Chronicles  |  Paramedic Shop  |  June 2026

Writing Their Own Scripts: New Zealand Moves to Give Paramedics Prescribing Authority

A landmark policy shift announced this month will allow qualified paramedics in Aotearoa to prescribe medicines for the first time. Here is what it means, how it came about, and why it matters across the Tasman too.

For as long as paramedics in New Zealand have been doing the job, there has been a gap between what they can do and what they can authorise. A paramedic could administer morphine for severe pain, draw up antibiotics for a suspected infection, and make complex clinical judgements in someone's kitchen at two in the morning. What they could not do was write a prescription. That authority sat with a doctor, a nurse practitioner or a pharmacist prescriber, and if none of those people were available, the patient waited, was transferred, or simply went without.

That is about to change. On 7 June 2026, New Zealand Health Minister Simeon Brown announced that suitably qualified paramedics would be granted prescribing authority, joining a small but growing list of non-medical health practitioners in New Zealand who can legally issue prescriptions. The Ministry of Health has already published a consultation document listing the proposed medicines, and the feedback deadline is 5 July 2026. Things are moving quickly.

The announcement was not a surprise to anyone who has been watching New Zealand's health workforce debates closely. It is, however, a significant moment, and one worth understanding properly.

The Standing Orders Problem

To understand why this matters, it helps to understand the system it is replacing, at least in part.

Until now, paramedics in New Zealand have administered prescription medicines under a framework of standing orders. A standing order is essentially a written instruction from an authorised prescriber, such as a doctor, authorising specific clinical personnel to supply or administer particular medicines in defined circumstances. It is not prescribing. The paramedic is executing someone else's authorisation rather than exercising their own clinical judgement to issue a prescription.

The Ministry of Health's consultation document is direct about the limitations of this system. It notes that standing orders were not designed to support contemporary models of mobile, community-based care and that the framework can result in administrative burden, fragmented accountability, inconsistent access to medicines, and delays in treatment for patients.

For paramedics working in rural and remote parts of Aotearoa, where the nearest prescribing practitioner might be an hour's drive away, these are not abstract administrative frustrations. They translate directly into patient outcomes. Someone in a small coastal community presenting to a paramedic with a urinary tract infection, a wound requiring antibiotic cover, or a respiratory exacerbation needing a steroid course has, until now, often needed to be transferred or referred solely to obtain a prescription for something the attending paramedic was entirely capable of identifying and managing.

The Health System Context

The timing of this change is not incidental. New Zealand's primary care system is under significant strain, and the pressure is sharpest in exactly the communities where paramedics are most likely to be first and sometimes only responders.

New Zealand has approximately 74 GPs per 100,000 people, compared to 116 in Australia and 122 in Canada. By January 2025, 33.1 percent of general practices were closed to new enrolments, driven largely by workforce and resourcing constraints. The Commonwealth Fund reported in 2024 that 73 percent of New Zealanders felt wait times for GP appointments were too long, up from 66 percent the year before. In rural areas, the situation is more acute still.

There is also a significant equity dimension. The Ministry's consultation document makes explicit that the challenges facing the health system disproportionately affect Māori, Pacific peoples, and communities in rural and remote areas. These are also, not coincidentally, communities where financial barriers to primary care access are most pronounced. Research published in Family Practice found that access inequities are most severe for Māori and those living in high-deprivation areas, and that cost barriers to both GP visits and prescription filling are common.

Into this context comes a paramedic workforce that is already present in these communities, already regulated, already delivering complex clinical care. Granting prescribing authority is, from one angle, simply catching the law up with the reality of what paramedics already do.

How the New System Will Work

The legal framework being used is the same one that already governs non-medical prescribers such as nurse prescribers, pharmacist prescribers, dietitian prescribers, and podiatrist prescribers. Under the Medicines Act 1981, these practitioners are classified as designated prescribers, meaning they can prescribe from a specified list of medicines within their defined scope of practice.

Te Kaunihera Manapou, the Paramedic Council of New Zealand, has applied to the Ministry of Health for designated prescribing authority for paramedics. The Council will then be responsible for setting the prescriber scope of practice, the education and training requirements, qualification standards, supervision arrangements, and ongoing competence frameworks for any paramedic wishing to prescribe.

Crucially, prescribing authority will not be automatic. It will require postgraduate prescribing education and competence assessment, and paramedics will need to operate within their prescribing scope of practice, maintain ongoing CPD, and work within employer clinical governance frameworks. The list of medicines a paramedic prescriber can authorise will be defined by a Specified Prescription Medicines List, or SPML, published in the New Zealand Gazette.

The Ministry has also confirmed that controlled drugs including opioids such as morphine, fentanyl and oxycodone, ketamine, and midazolam will require separate regulations under the Misuse of Drugs Regulations 1977. These are medicines paramedics already administer routinely under standing orders; the change would mean qualified paramedic prescribers could initiate and authorise these rather than simply execute pre-authorised orders.

What the Proposed Medicines List Reveals

The consultation document includes a detailed proposed SPML, and it gives a clear picture of the scope being contemplated. This is not a narrow list confined to emergency interventions. It spans a wide range of clinical contexts.

A few items on this list are worth pausing on. The inclusion of benzathine penicillin for rheumatic fever prevention reflects one of New Zealand's most pressing health inequities. Rheumatic fever rates in New Zealand remain among the highest in the developed world, with Māori and Pacific children disproportionately affected. Enabling paramedics to prescribe penicillin for streptococcal throat infections in high-risk communities could have meaningful downstream effects on a disease that causes preventable heart damage.

The vaccine provision is also significant. Listing vaccines as a class would allow paramedic prescribers to participate in the national immunisation programme, opening up a community-based delivery channel that does not currently exist through the ambulance sector.

The inclusion of emergency contraception and oral contraceptives likewise reflects a recognition that paramedics increasingly operate in primary care and community settings, not simply emergency response.

Industry Response: Welcome, With Caveats

Hato Hone St John, which provides ambulance services to approximately 88 percent of New Zealand, welcomed the announcement. Jon Moores, the organisation's Deputy Chief Executive for Clinical Services, described it as an important step in the ongoing development of the paramedic profession. But the organisation was also careful to flag the conditions it considers essential for safe implementation.

Moores also raised a question that will need careful consideration as implementation is planned: the risk that prescribing authority could inadvertently increase demand on ambulance services, with people calling 111 for conditions they might otherwise take to a GP. There are practical and financial implications around workforce development, clinical support systems, and medicines management that Hato Hone St John said would need to be resolved.

These are legitimate concerns, and they echo the implementation challenges seen elsewhere. The United Kingdom has had nurse prescribers since 1992 and pharmacist prescribers since 2003, and the evidence base for non-medical prescribing is substantial. Studies have consistently found that appropriately trained non-medical prescribers deliver safe, effective, and patient-centred care when supported by robust governance frameworks. But the governance piece matters as much as the clinical piece.

Where Australia Fits In

For Australian paramedics watching developments across the Tasman, this shift carries obvious relevance. Australia does not yet have a nationally consistent framework for paramedic prescribing, though the Victorian Paramedic Practitioner model provides a pathway for a more limited cohort of advanced practitioners to prescribe within a specific clinical role. What New Zealand is proposing is broader: a designated prescribing pathway available to any paramedic who meets the education and competence requirements, across the full range of existing paramedic scopes of practice.

The Australasian College of Paramedicine has been advocating for expanded paramedic scope across both countries for years. The NZ development adds momentum to a regional conversation about the untapped potential of the paramedic workforce as a primary care resource. With the ACP's Australasian Paramedicine Workforce Survey highlighting the profession's growing clinical capability and community reach, the policy environment in both countries is shifting in the same direction, even if the pace differs.

For those working in extended care, community paramedicine, or clinical leadership roles on either side of the Tasman, the New Zealand model will be worth watching closely as it moves from consultation to implementation.

What Happens Next

The consultation on the proposed medicines list closes on 5 July 2026. Following that, several steps are required before any paramedic can actually write a prescription. The Specified Prescription Medicines List needs to be gazetted by the Director-General of Health. Separate regulations under the Misuse of Drugs Regulations 1977 are needed for controlled drugs. Te Kaunihera Manapou must develop, accredit, and implement the prescribing education and training programmes, establish the paramedic prescriber scope of practice, and put supervision and mentoring requirements in place.

None of that happens overnight. This is a framework being built from the ground up, and building it well matters more than building it fast. The Ministry has noted that the consultation is being released now specifically to give education and training providers lead time to develop paramedic prescribing courses. That is a signal that the implementation timeline is being taken seriously.

The profession in New Zealand has reached a point where the gap between clinical capability and legal authority is no longer sustainable. Closing that gap carefully, with proper safeguards and investment in training, is the challenge now. The announcement signals the will to do it. The work ahead will determine whether that will translates into real change for the patients and communities who need it most.